Clinical trials
Completed Dyskinesias trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 7 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 13 |
| Great Lakes NeuroTechnologies Inc. | 6 |
| Novartis Pharmaceuticals | 6 |
| AbbVie (prior sponsor, Abbott) | 4 |
| Adamas Pharmaceuticals, Inc. | 4 |
| Auspex Pharmaceuticals, Inc. | 3 |
| EMD Serono | 3 |
| Louisiana State University Health Sciences Center Shreveport | 3 |
| US Department of Veterans Affairs | 3 |
| AbbVie | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyskinesias | 69 |
| Parkinson Disease | 52 |
| Movement Disorders | 13 |
| Tremor | 10 |
| Parkinsonian Disorders | 7 |
| Neurologic Manifestations | 5 |
| Psychotic Disorders | 5 |
| Central Nervous System Diseases | 4 |
| Hypokinesia | 4 |
| Nervous System Diseases | 4 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.